Lessons learned from two decades of anticancer drugs. TiPS 38, 852-872.
Tremendous efforts have been made to elucidate the basis of cancer biology with the aim of promoting anticancer drug development. Especially over the past 20 years, anticancer drug development has developed from conventional cytotoxic agents to target-based and immune-related therapies. Consequently, more than 200 anticancer drugs are available on the market. However, anticancer drug development still suffers high attrition during the later phases of clinical development and is considered to be a difficult and risky therapeutic category within the drug development arena…
By Chloe Atkinson|2022-11-28T14:10:47+00:00June 17th, 2021|Comments Off on Lessons learned from two decades of anticancer drugs. TiPS 38, 852-872.